← Back to headlines
FDA Approves Afrezza, Inhaled Insulin for Children and Adolescents with Diabetes
MannKind has announced FDA approval for Afrezza®, the first and only inhaled mealtime insulin specifically for children and adolescents aged 6 and older living with diabetes.
29 May, 16:30 — 29 May, 16:30
Related Stories
Instagram head Mosseri denies encouraging suppression of child social media risks
17m ago
SpaceX plans to build the ‘biggest launch site on Earth’ for $100 billion in Louisiana - CNN
22m ago
SpaceX Plans $100 Billion Starship Launch Site in Louisiana
52m ago
Indonesia's First Aircraft Carrier to Debut at TNI Anniversary
56m ago